2,200
Participants
Start Date
February 19, 2024
Primary Completion Date
February 20, 2025
Study Completion Date
February 20, 2025
Ticagrelor 90 MG
Patients in the treatment group will receive Ticagrelor 180 mg as a loading dose and 90 mg twice daily as a maintenance dose for 30 days. After 30-day doses will be according to standards clinical practice guidelines.
Clopidogrel
Patients in the control group will receive Clopidogrel 600 mg as a loading dose and 75 mg twice daily as a maintenance dose for 30 days. After 30-day doses will be according to standards clinical practice guidelines.
National Institute of Cardiovascular Diseases, Karachi
PharmEvo Pvt Ltd
INDUSTRY
National Institute of Cardiovascular Diseases, Pakistan
OTHER